Cargando…
Calpain activation and progression of inflammatory cycles in Parkinson’s disease
Parkinson’s disease (PD) is a progressive, neurodegenerative condition of the central nervous system (CNS) affecting 6.3 million people worldwide with no curative treatments. Current therapies aim to mitigate PD’s effects and offer symptomatic relief for patients. Multiple pathways are involved in t...
Autores principales: | Gao, Andrew, McCoy, Hannah M., Zaman, Vandana, Shields, Donald C., Banik, Naren L., Haque, Azizul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723550/ https://www.ncbi.nlm.nih.gov/pubmed/35090325 http://dx.doi.org/10.31083/j.fbl2701020 |
Ejemplares similares
-
Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
por: Zaman, Vandana, et al.
Publicado: (2022) -
Regulation of enolase activation to promote neural protection and regeneration in spinal cord injury
por: McCoy, Hannah M., et al.
Publicado: (2022) -
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis
por: Trager, Nicole, et al.
Publicado: (2013) -
Implications of enolase in the RANKL-mediated osteoclast activity following spinal cord injury
por: SHAMS, Ramsha, et al.
Publicado: (2021) -
New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection
por: Haque, Azizul, et al.
Publicado: (2018)